News

The common theme at the maker of Wegovy and at UnitedHealth may be investors' sudden awareness of cost-cutting pressure.
Stephen Hemsley hasn't been CEO at UnitedHealth Group in nearly a decade yet he's never really left. Since that day, the company's stock has fallen from $610 a share to $308 on Tuesday, an ...
UnitedHealth is almost as oversold as during the Great Financial Crisis, with its monthly RSI sitting at 33. Find out why UNH ...
UnitedHealth shares dropped 55%, facing lawsuits and claim rejection issues. Management changes raise questions on recovery.
The Department of Justice has launched an investigation of UnitedHealth Group for possible criminal Medicare fraud, according ...
Stephen Hemsley would get stock options after three years, in some cases even if he doesn’t stay that long ...
Shares of UnitedHealth Group plunged more than 18% following a report that the Department of Justice is carrying out a ...
The Wall Street Journal published a series of investigative articles last year that reported on questionable practices by UnitedHealth and other insurers that boosted their payments in the Medicare ...
We don't need to dwell on the lack of detail behind Andrew Witty stepping down as CEO of UnitedHealth ( UNH) for "personal ...
Former UnitedHealth Group chief executive officer Stephen Hemsley to replace Andrew Witty. Here's what we know.
UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ ...
The move comes five months after one of the company’s top executives was killed after being shot as he walked to an investor conference in ...